Loading…
CIK 0001587114 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ecor1-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AARDVARK THERAPEUTICS INC | COM | $2.4M | 0.1% | 410,894 SH | New |
| AKTIS ONCOLOGY INC | COM | $155.5M | 7.6% | 4,824,469 SH | New |
| ANAPTYSBIO INC | COM | $531.9M | 25.9%Prev: 10.4% | 7,880,094 SH | Increased |
| ATARA BIOTHERAPEUTICS INC | COM NEW | $17.8M | 0.9%Prev: 0.3% | 1,552,000 SH | Increased+978,817 SH |
| AURA BIOSCIENCES INC | COM | $11.8M | 0.6% | 1,666,667 SH | New |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $21.5M | 1.0% | 2,823,126 SH | New |
| CG ONCOLOGY INC | COM | $146.1M | 7.1% | 2,055,800 SH | New |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $75.8M | 3.7%Prev: 4.0% | 1,389,276 SH | Increased |
| EIKON THERAPEUTICS INC | COM | $9.6M | 0.5% | 732,606 SH | New |
| ELOXX PHARMACEUTICALS INC | COM NEW ADDED | $5.6M | 0.3% | 400,000 SH | New |
| ERASCA INC | COM | $6.0M | 0.3% | 330,000 SH | New |
| ETON PHARMACEUTICALS INC | COM | $78.6M | 3.8%Prev: 1.7% | 2,171,938 SH | Increased+141,394 SH |
| FIRST TRACKS BIOTHERAPEUTICS | ORD SHS ADDED | $63.9M | 3.1% | 3,174,519 SH | New |
| FULCRUM THERAPEUTICS INC | COM | $24.0M | 1.2% | 6,549,866 SH | New |
| HELIX ACQUISITION CORP III USD | CL A ORD SHS | $2.1M | 0.1% | 200,000 SH | New |
| LAKEFRONT BIOTHERAPEUTICS NV | SPON ADR | $50.0M | 2.4% | 1,667,119 SH | New |
| LEGEND BIOTECH CORP | SPONSORED ADS | $23.1M | 1.1% | 800,000 SH | New |
| MBX BIOSCIENCES INC | COM | $21.4M | 1.0%Prev: 0.8% | 388,500 SH | Increased-761,294 SH |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | $318K | 0.0% | 1,000,000 SH | New |
| NEUROGENE INC | COM | $40.0M | 1.9%Prev: 1.1% | 1,271,342 SH | Increased |
| NURIX THERAPEUTICS INC | COM | $6.6M | 0.3% | 270,000 SH | New |
| ODYSSEY THERAPEUTICS INC | COMMON STOCK ADDED | $10.4M | 0.5% | 555,555 SH | New |
| ORIC PHARMACEUTICALS INC | COM | $72.9M | 3.5%Prev: 1.0% | 6,728,116 SH | Increased+5,110,048 SH |
| PHARVARIS N V | COM | $8.1M | 0.4% | 235,000 SH | New |
| PHATHOM PHARMACEUTICALS INC | COM | $6.8M | 0.3% | 625,000 SH | New |
| RELAY THERAPEUTICS INC | COM | $13.1M | 0.6% | 697,948 SH | New |
| STOKE THERAPEUTICS INC | COM | $24.0M | 1.2% | 735,000 SH | New |
| SURROZEN INC | *W EXP 08/01/203 | $115K | 0.0%Prev: 0.0% | 4,444 SH | Decreased-62,221 SH |
| ZENAS BIOPHARMA INC | COM | $20.0M | 1.0% | 789,500 SH | New |
| ZURA BIO LTD | CLASS A ORD SHS | $7.0M | 0.3% | 1,179,715 SH | New |
| ZYMEWORKS INC | COM | $600.4M | 29.2%Prev: 17.1% | 22,970,388 SH | Increased |
| 13F-HR |
| 0000935836-26-000415 |
| $2.06B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000935836-25-000506 | $1.69B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000935836-26-000270 | $2.36B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000935836-25-000338 | $1.69B | View |